Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I
Clinical trial NCT02371226 · COMPLETED
Trial details
- NCT number
- NCT02371226
- Sponsor
- ArmaGen, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2017-01-23
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.